Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer.

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Masimo Corporation (NASDAQ:MASI) benefits from both growth and recurring revenue by selling sensor housings (by expanding the customer base for them) and sensors. Masimo is also opening a new ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Now, it seems unlikely that this situation will change soon. On Friday, a Delaware jury found that health monitoring technology company Masimo infringed on some of Apple’s earlier smartwatch patents.

Masimo has obtained an import ban for an Apple Watch feature in the USA. Apple sued back and won a Pyrrhic victory. A new chapter has been added to the conflict between Apple and medical ...

Apple has been awarded the paltry sum of $250 in damages after a court in the US ruled that wearable tech rival Masimo infringed on two of its smartwatch design patents. However, Apple has failed ...